Yunnan Baiyao admits to buying illegal Ginkgo biloba extract
-
Last Update: 2015-05-26
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
In response to the Circular of the State Food and Drug Administration of the people's Republic of China on purchasing illegal Ginkgo biloba extract from 24 pharmaceutical enterprises including Yunnan Baiyao, Yunnan Baiyao issued another announcement yesterday evening, admitting to purchase 6.9 tons of Ginkgo biloba extract from five batches of Guilin Xingda According to the announcement, Yunnan Baiyao said that its wholly-owned subsidiary traditional Chinese medicine resources company, in response to the needs of downstream customer Yunnan Xitao green Pharmaceutical Co., Ltd Anning Branch to carry out foreign business, purchased five batches of 6.9 tons Ginkgo biloba extract from Guilin Xingda and sold it to upstream and downstream customers Up to now, all the goods have been sent to Anning Branch of Yunnan Xitao green Pharmaceutical Co., Ltd And said that the behavior belongs to the normal business of traditional Chinese medicine resources company In addition to the above business, the traditional Chinese medicine resource company has not had any production, procurement and sales business of Ginkgo biloba extract Yunnan Baiyao also disclosed that the company had reported to Yunnan food and Drug Administration on May 22, 2015, and notified Anning Branch of Yunnan Xitao green Pharmaceutical Co., Ltd to conduct follow-up investigation on Ginkgo biloba extract Previously, on May 19, the State Food and Drug Administration disclosed that Guilin Xingda Pharmaceutical Co., Ltd changed the production process of Ginkgo biloba extract without authorization, and purchased Ginkgo biloba extract produced by hydrochloric acid process from unqualified enterprises, and sold the purchased extract to a total of 24 other pharmaceutical manufacturers, falsifying the purchase account of raw materials and production inspection records, including Yunnan Baibai Pharmaceutical Co., Ltd Pharmaceutical Group, traditional Chinese medicine resource company and other pharmaceutical enterprises.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.